ESPL1 and breast cancer: Various cancer types, including BC (Finetti et al., 2014), bladder cancer (Zhang W. et al., 2024), esophageal carcinoma (Liu et al., 2021), gastric cancer (Zhang B. et al., 2024), liver cancer (Song et al., 2022), lung cancer (Nie et al., 2022), and endometrial cancer (Yang et al., 2024), exhibit elevated ESPL1 expression.